Risk of suicide in users of β-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors

British Journal of Clinical Pharmacology, Supplement

Volumn 52, Issue 3, 2001, Pages 313-318

  Sørensen, Henrik Toft ^a   Mellemkjær, Lene ^b   Olsen, Jørgen H ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

Angiotensin enzyme inhibitors; Calcium channel blockers; Depression; Epidemiology; Suicide; adrenoceptor blockers

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DENMARK; DRUG THERAPY; FEMALE; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RISK FACTOR; STATISTICS; SUICIDE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; COHORT STUDIES; DENMARK; DRUG THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; RISK FACTORS; SUICIDE;

EID: 18044401972     PISSN: 02643774     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2001.01442.x     Document Type: Article

References (26)

1. Waal HJ. Propranolol-induced depression. Br Med J 1967; ii: 50.
2. Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA 1986; 255: 357-360.
3. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 1996; 7: 478-484.
4. Gerstman 1313, Jolson HM, Bauer M, Cho P, Livingston JM, Platt R. The incidence of depression in new users of beta-blockers and selected antihypertensives. J Clin Epidemiol 1996; 49: 809-815.
5. Bright R A, Everitt DE. Beta-blockers and depression. Evidence against an association. JAMA 1992; 267: 1783-1787.
6. Thiessen BQ, Wallace SM, Blackburn JL, Wilson TW, Bergman U. Increased prescribing of antidepressants subsequent to beta-blocker therapy. Arch Intern Med 1990; 150: 2286-2290.
7. Patten SB. Propranolol and depression: evidence from antihypertensive trials. Can J Psychiatry 1990; 35: 257-259.
8. Ried LD, McFarland BH, Johnson RE, Brody KK. Beta-blockers and depression: the more the murkier? Ann Pharmacother 1998; 32: 699-708.
9. Biriell C, McEwen Sanz E. Depression associated with diltiazem. Br Med J 1989; 299: 796.
10. Dassylva B. Verapamil may cause depression. Can J Psychiatry 1993; 38: 299-300.
11. Hullett FJ, Potkin SG, Levy AB, Ciasca R. Depression associated with nifedipine-induced calcium channel blockade. Am J Psychiatry 1988; 145: 1277-1279.
12. Lindberg G, Bingefors K, Ranstam K, Rastam L, Melander A. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study. Br Med J 1998; 316: 741-745.
13. Gasse C, Derby LE, Vasilakis C, Jick H. Risk of suicide among users of calcium channel blockers: population based, nested case-control study. Br Med J 2000; 320: 1251.
14. Patten SB, Williams JV, Love EJ. Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population. Can J Psychiatry 1996; 41: 469-476.
15. Olsen JH, Sorensen HT, Friis S, et al. Cancer risk in users of calcium channel blockers. Hypertension 1997; 29: 1091-1094.
16. Capellá D. Descriptive tools and analysis. In Drug Utilization Studies: Methods and Uses ed. Dukes MNG. Copenhagen: WHO Regional Publications, 1993: 55-78. (European Series no. 45).
17. Svendsen TL. Beta-receptorblokkerende midier. In Ltvgemiddclkataloget. Copenhagen: Dansk Lagemiddel Information eds Kristensen MB, Friis H, Rassing MR. 1998: 179-183.
18. Lægeforeningens Medicinfortegnelse Copenhagen. Lægeforeningens Forlag, 1994.
19. Sundhedsstyrelsen. Causes of Death in Denmark 1996. Munksgârds Forlag, 1996.
20. Rothman KJ, Boice JD Jr. Epidemiologie analysis with a programmable calculator. Washington, DC. Government Printing Office. (DHHS publication no. (NIH) 79-1649), 1979.
21. Beers MH, Passman LJ. Antihypertensive medications and depression. Drugs 1990; 40: 792-799.
22. Conant J, Engler R, Janowsky D, Maisel A, Gilpin E, LeWinter M. Central nervous system side effects of beta-adrenergic blocking agents with high and low lipid solubility. J Cardiovasc Pliarmacol 1989; 13: 656-661.
23. Kyvik KO, Stenager EN, Green A, Svendsen A. Suicides in men with IDDM. Diabetes Care 1994; 17: 210-212.
24. Breslau N. Migraine, suicidal ideation, and suicide attempts. Neurology 1992; 42: 392-395.
25. Edwards JG. Depression, antidepressants, and accidents. Br Med J 1995; 311: 887-888.
26. Lavorato DH, Patten SC. Antihypertensive medications and depression, an historical perspective. Pharmacoepidemiol Drug Safety 1999; 8: 355-359.